Government support of dementia caregiving across the continuum important: poll
By
Kimberly Bonvissuto
Aug 06, 2024
A recent poll of more than 1,000 older adults found they overwhelmingly want the government to support dementia care across the care continuum, including in assisted living settings.
Communities break fundraising record during The Longest Day
By
Foster Stubbs
Jul 24, 2024
63 Charter Senior Living communities across the nation raised money for Alzheimer’s research as part of the Alzheimer’s Association’s The Longest Day initiative. Find out more, and learn how to submit...
Assisted living providers to face increased regulation from bill headed for governor’s signature
By
Kimberly Bonvissuto
Apr 08, 2024
A bill expected to become law and targeting assisted living reform in Arizona addresses some best practices long touted by industry experts, but it also brings an increase in regulations for providers.
Alzheimer’s Association calls for federal involvement to increase dementia care workforce, training...
By
Lois A. Bowers
Jan 29, 2024
“Congress should consider the steps it can take at the federal level, including expanding the necessary workforce and improving dementia training standards and access,” as part of efforts to “help...
Alzheimer’s blood tests claim ‘very high accuracy’ via screening results, latest research shows
By
Aaron Dorman
Sep 07, 2023
A new blood test could provide an efficient and simple thumbs-up, thumbs-down method for screening for Alzheimer’s disease, researchers say.
Congressional report slams FDA, drugmaker over approval of Alzheimer’s drug Aduhelm
Dec 29, 2022
The controversy over aducanumab (Aduhelm) stretches back to its June 2021 approval by the US Food and Drug Administration.
‘Magic tables’ provide stimulation for memory care residents
By
Kimberly Bonvissuto
May 06, 2022
Table top gaming consoles — so-called magic tables — are taking off in memory care communities, providing an easy way to stimulate the brains of those with memory impairing diseases.
Medicare will only cover Aduhelm for patients in clinical trials
Apr 08, 2022
The decision is meant to protect patients while gathering more clinical data on whether the medication actually helps slow declines in thinking.
Should residents’ access to Alzheimer’s drug be restricted?
By
Lois A. Bowers
Jan 18, 2022
You have until Feb. 10 to share your comments with CMS about its recent proposal related to Alzheimer’s drug aducanumab (Aduhelm).
Medicare may rethink premium hike for pricey Alzheimer’s drug
Jan 10, 2022
The announcement comes shortly after Aduhelm maker Biogen cut the price of the drug by about half, from $56,000 to $28,000 a year.